Literature DB >> 26565574

Critical Appraisal and Review of Management Strategies for Severe Fibrosis During Penile Implant Surgery.

Landon Trost1, Mukul Patil2, Andrew Kramer3.   

Abstract

INTRODUCTION: Penile corporal fibrosis represents a challenging clinical scenario for surgeons placing penile prostheses (PP). Because of its rarity, a small number of series with limited follow-up have reported outcomes in this cohort. AIM: The aim of this study was to perform a critical appraisal of the corporal excavation technique, discuss its relevance to contemporary practice, and review alternative surgical methods and outcomes.
METHODS: A critical review was performed of the 2006 article by Montague and Angermeier, "Corporeal excavation: new technique for penile prosthesis implantation in men with severe corporeal fibrosis." Notable inclusions and omissions were described, with emphasis placed on methodology and outcomes. A PubMed search from 1990 to June 2015 was then performed to review and summarize the literature on managing corporal fibrosis during PP surgery. MAIN OUTCOME MEASURES: The main outcome measures used were the major contributions and limitations of the 2006 article describing outcomes of the corporal excavation technique.
RESULTS: Corporal excavation is a relevant surgical technique for managing severe corporal fibrosis. Compared with alternatives, excavation achieves successful placement of PP without need for grafting and with few complications. The article was limited by several notable omissions including relevant patient demographic and disease characteristics, patient selection, and minimal descriptions of complications and outcomes. Alternative techniques include use of specialized dilators, counter incisions, reconstruction with graft placement, minimal scar tissue excision, and endoscopic resection. Because of limited data, no specific algorithm for managing corporal fibrosis can be prescribed.
CONCLUSIONS: Corporal fibrosis is a challenging clinical scenario and requires surgical experience and specialized techniques to manage appropriately. Corporal excavation represents one of several viable techniques, which may be chosen based on surgeon's preference and clinical factors.
© 2015 International Society for Sexual Medicine.

Entities:  

Keywords:  Erectile Dysfunction; Peyronie's Disease; Revision; Salvage

Mesh:

Year:  2015        PMID: 26565574     DOI: 10.1111/jsm.12985

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  6 in total

Review 1.  Damage Control Considerations During IPP Surgery.

Authors:  David Y Yang; Tobias S Kohler
Journal:  Curr Urol Rep       Date:  2019-01-30       Impact factor: 3.092

2.  Inflatable Penile Prosthesis Insertion in Men with Severe Intracorporal Fibrosis.

Authors:  Bruce B Garber; Caitlin Lim
Journal:  Curr Urol       Date:  2017-05-30

Review 3.  Multicenter surgical outcomes of penile prosthesis placement in patients with corporal fibrosis and review of the literature.

Authors:  Kevin Krughoff; Priyanka Bearelly; Michel Apoj; Nicolas A Munarriz; Nannan Thirumavalavan; Shu Pan; Martin S Gross; Ricardo M Munarriz
Journal:  Int J Impot Res       Date:  2020-11-17       Impact factor: 2.896

Review 4.  The International Penile Prosthesis Implant Consensus Forum: clinical recommendations and surgical principles on the inflatable 3-piece penile prosthesis implant.

Authors:  Eric Chung; Carlo Bettocchi; Paulo Egydio; Chris Love; Daniar Osmonov; Sean Park; David Ralph; Zhong Cheng Xin; Gerald Brock
Journal:  Nat Rev Urol       Date:  2022-06-16       Impact factor: 16.430

Review 5.  The use of penile prostheses in the management of priapism.

Authors:  Jonathan Moore; Thomas F Whelan; Gavin M Langille
Journal:  Transl Androl Urol       Date:  2017-11

Review 6.  Penile prosthesis implant in the special populations: diabetics, neurogenic conditions, fibrotic cases, concurrent urinary continence surgery, and salvage implants.

Authors:  Eric Chung
Journal:  Asian J Androl       Date:  2020 Jan-Feb       Impact factor: 3.285

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.